Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection-Reference-Cited by-同舟云学术

Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection

Published:2015-07-14 Issue:5 Volume:20 Page:621-631
ISSN:1382-4147
Container-title:Heart Failure Reviews
language:en
Short-container-title:Heart Fail Rev

Author:

Madonna Rosalinda,Cadeddu Christian,Deidda Martino,Mele Donato,Monte Ines,Novo Giuseppina,Pagliaro Pasquale,Pepe Alessia,Spallarossa Paolo,Tocchetti Carlo Gabriele,Zito Concetta,Mercuro Giuseppe

Funder

Ministry of University and Scientific Research, Italy, PRIN (Research Program of National Interest)

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10741-015-9497-4.pdf

Reference102 articles.

1. Swain SM, Whaley FS, Ewer MS (2003) Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97:2869–2879

2. Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25:3808–3815

3. Ewer SM, Ewer MS (2008) Cardiotoxicity profile of trastuzumab. Drug Saf 31:459–467